Back
ESC Premium Access

Efficacy and safety of oral anticoagulant versus antiplatelet therapy for secondary prevention of cardiovascular disease in patients without atrial fibrillation

Session: Poster Session 3 - Antiplatelet therapy
Topic: Anticoagulants
Speaker: Assistant Professor F. Ricci (Chieti, IT)
Event: ESC Congress 2019

Congress Presentation

About the speaker

Assistant Professor Fabrizio Ricci

G. d Annunzio University of Chieti-Pescara, Chieti (Italy)
2 presentations
0 follower

4 more presentations in this session

A randomized, pharmacodynamic comparison of low dose ticagrelor (60mg bid) to low dose prasugrel (5mg od) in patients with prior myocardial infarction: the ALTIC-2 study

Speaker: Doctor I. Lianos (Athens, GR)

Access
Abstract
Slides
Thumbnail

Triple vs. double antithrombotic therapy in patients needing oral anticoagulation undergoing percutaneous coronary intervention: a meta-analysis

Speaker: Doctor D. Errigo (Turin, IT)

Access
Abstract
Slides
Thumbnail

Combined with ticagrelor, 50 mg aspirin daily can reduce bleeding events without increasing ischaemic risk compared with 75-100 mg aspirin daily in coronary artery disease patients

Speaker: Doctor J. Li (Beijing, CN)

Access
Abstract
Thumbnail

Bleedings during antithrombotic therapy: a blessing in disguise

Speaker: Doctor D. Cosmi (Perugia, IT)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster Session 3 - Antiplatelet therapy

Speakers: Assistant Professor F. Ricci, Doctor I. Lianos, Doctor D. Errigo, Doctor J. Li, Doctor D. Cosmi
Access
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb